Revenue ($USD) : $8,924,895,000
Revenue (foreign currencies) : €8,499,900,000
R&D spend : $568,260,000.00
Employees : 65,000
Fiscal year end : 12/31/22
CEO : Anna Maria Braun, CEO; Jean-Claude Dubacher, U.S. CEO

With employees in 64 countries, B. Braun Melsungen manufactures over 5,000 medical devices and pharmaceutical products, which it supplements with an extensive range of services.

According to the German company’s most recent annual report, the offerings include digital components that improve customers’ processes, increase safety and ease the burden on medical professionals. B. Braun products and services cover 15 therapeutic areas and applications grouped into three divisions: Hospital Care, Aesculap (surgical and interventional), and Avitum (chronic disease treatments).

Multiple generations of the Braun family have owned the company since its founding in the 19th century, with Anna Maria Braun presently serving as CEO. In the company’s most recent annual report, she described the company’s Spaceplus infusion pump system, which can be connected to hospital data management systems. There’s also the Aesculap Aeos robot-assisted surgical microscope for the operating room.

Said Braun: “New technologies offer possibilities for treating people around the world using the highest medical standards, while also ensuring the affordability of health care through greater efficiency.” –CN